External pharmaceutical composition for treating mammary gland diseases and preparation method thereof

A technology for external use of drugs and breast diseases, applied in drug combinations, medical preparations containing active ingredients, diseases, etc., can solve problems such as human hormone imbalance and induction of endometrial cancer

Inactive Publication Date: 2012-07-11
李新民
View PDF5 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Long-term use may induce the risk of endometrial cancer, and may also lead to an imbalance in the balance of human hormones, so it is not suitable for routine therapy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • External pharmaceutical composition for treating mammary gland diseases and preparation method thereof
  • External pharmaceutical composition for treating mammary gland diseases and preparation method thereof
  • External pharmaceutical composition for treating mammary gland diseases and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Embodiment 1 plaster preparation method

[0021] 1) Preparation of extract powder:

[0022] prescription:

[0023] Preparation:

[0024] The above eighteen flavors are mixed with Ligusticum chuanxiong, dried blood, pangolin, frankincense (made), and myrrh (made), crushed, sieved through a 100-mesh sieve, and set aside. Separately take Panax notoginseng and grind it separately, pass through a 100-mesh sieve, grind borneol and camphor into fine powder, mix them with the above-mentioned fine powder evenly, and set aside. The rest of Bupleurum and other eight flavors are decocted three times with water, the first time is 2 hours, the second and third time are 1 hour each, the decoction is combined, filtered, the filtrate is concentrated to a clear paste with a relative density of 1.35-1.38 (80°C), and dried , crushed into fine powder for later use, obtained extract powder.

[0025] 2) Plaster preparation:

[0026] prescription:

[0027] Preparation:

[0028] Take...

Embodiment 2

[0029] The preparation method of embodiment 2 cataplasm

[0030] prescription:

[0031]

[0032] Preparation method: Add aluminum glycolate and diethylamine tetraacetic acid into glycerin, mix thoroughly, then add polyacrylic acid, and continue mixing. Separately take crospovidone and citric acid and dissolve them in water; respectively take equal parts of the above solution and extract powder and add in sequence, mix thoroughly, apply the mixture on the non-woven fabric, add a cover lining, cut into 1000 sticks, Instantly.

Embodiment 3

[0033] Embodiment 3 cream preparation method

[0034] prescription:

[0035] Preparation:

[0036] (1) Add triethanolamine to ethanol, heat glycerin in a water bath to 80°C; (2) take stearic acid and melt it on a water bath, add lanolin and vaseline and keep the temperature at 80°C; under constant stirring, mix ( 2) solution is gradually added to the isothermal solution (1), removed from the water bath, and stirred until it becomes a paste.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an external pharmaceutical composition for treating mammary gland diseases and a preparation method of the external pharmaceutical composition, and belongs to the field of pharmaceutical preparation. The external pharmaceutical composition for treating mammary gland disease is uniform in content, good in stability, high in dissolution rate, simple and convenient in preparation method and suitable for industrial production.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, and in particular relates to an external pharmaceutical composition for treating breast diseases and a preparation method thereof. Background technique [0002] In recent years, due to the improvement of living standards, less exercise, environmental pollution, increased pressure and other reasons, people have endocrine disorders, decreased immunity, and the incidence of breast disease and breast cancer has increased year by year, and they are younger. The cause is still unclear, but it may be related to an imbalance in the ratio of progesterone to estrogen. Modern medical research proves that the canceration rate of mammary gland hyperplasia reaches 8.8%~21.8%. In particular, middle-aged women suffer from cystic hyperplasia of the mammary gland, and the chance of canceration is dozens of times higher than that of ordinary women. Therefore, a thorough cure of mammary gland hyperplasia...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9066A61K9/70A61P15/14
Inventor 李新民
Owner 李新民
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap